Efficacy and Safety Study of Moxidectin in Adults With Scabies
Status:
Not yet recruiting
Trial end date:
2024-03-30
Target enrollment:
Participant gender:
Summary
Moxidectin is not approved to treat scabies in humans. The effective dose of moxidectin to
treat scabies is not known. This study aims to assess the efficacy of a single administration
of 8 mg, 16 mg, or 32 mg moxidectin per oral in achieving Scabies Complete Cure at Day 28.
This study also aims to assess the safety of three strengths of single moxidectin doses in
adults with scabies.